Disease Info Card

Jaundice, Chronic Idiopathic

Information about Jaundice, Chronic Idiopathic: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Jaundice, Chronic Idiopathic

Most recent studies have shown that Jaundice, Chronic Idiopathic shares some biological mechanisms with anemia-hemolytic, cholelithiasis, cholestasis, conjugated-hyperbilirubinemia, crigler-najjar-syndrome, drug-induced-liver-injury, gilbert-disease-(disorder), hepatitis, hepatitis-a, hepatolenticular-degeneration, hyperbilirubinemia, hyperbilirubinemia-hereditary, icterus, intrahepatic-cholestasis, liver-cirrhosis, liver-diseases, liver-neoplasms, neonatal-jaundice, pregnancy-complications, rotors-syndrome.

Among the many pathways, these few ones have gauged particular interests from scientists studying Jaundice, Chronic Idiopathic, and have been seen in publications frequently: Aging, Aminophospholipid Transport, Anion Transport, Bilirubin Transport, Blood Coagulation, Coagulation, Conjugation, Drug Resistance, Drug Transport, Excretion, Localization, Methotrexate Transport, Organic Anion Transport, Pathogenesis, Pigment Accumulation, Pigmentation, Protein Maturation, Reverse Transcription, Secretion, Transport

Quite a number of genes have been found to play important roles in Jaundice, Chronic Idiopathic, such as ABCB11, ABCB4, ABCB6, ABCC1, ABCC2, ABCC3, ABCC4, ABCC6, ABCC8, ALB, ATP8B1, CFTR, HMBS, IBSP, KLHL1, MARCKSL1, MDM4, MSH3, WLS. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.